Hypertension Clinical Trials in Salt Lake City, Utah

8 studies are recruiting for hypertension in Salt Lake City, Utah right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

   The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adj…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Clinical Trial Site, Salt Lake City, Utah

   Locations

   1153 in total

   Run by

   Alnylam Pharmaceuticals

   See if you can join NCT07181109 on ClinicalTrials.gov

2. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

   This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Olympus Family Medicine, Salt Lake City, Utah

   Locations

   1143 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07064473 on ClinicalTrials.gov

3. THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

   The primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncontrolled hypertension (HTN) receiving 0 - 2 anti-hypertensive drugs of different classes in whom the anti-hypertensive medications will be sto…

   Stage

   Not phased

   Ages

   22 to 75

   Site

   St Marks Hospital, Salt Lake City, Utah

   Locations

   50 in total

   Run by

   SoniVie Inc.

   See if you can join NCT06559891 on ClinicalTrials.gov

4. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

   The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

   Stage

   Not phased

   Ages

   0 to 20

   Site

   University of Utah, Salt Lake City, Utah

   Locations

   52 in total

   Run by

   Duke University

   See if you can join NCT04278404 on ClinicalTrials.gov

5. Global Paradise System US Post Approval Study

   The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a…

   Stage

   Not phased

   Ages

   18 and older

   Site

   St. Mark's Hospital, Salt Lake City, Utah

   Locations

   43 in total

   Run by

   ReCor Medical, Inc.

   See if you can join NCT06297291 on ClinicalTrials.gov

6. Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

   A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   Vanda Investigative Site, Salt Lake City, Utah

   Locations

   28 in total

   Run by

   Vanda Pharmaceuticals

   See if you can join NCT07090161 on ClinicalTrials.gov

7. Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

   Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation strategy, but also for those individuals who suffer from…

   Stage

   Not phased

   Ages

   18 to 100

   Site

   University of Utah, Salt Lake City, Utah

   Locations

   7 in total

   Run by

   International Consortium of Circulatory Assist Clinicians

   See if you can join NCT06039176 on ClinicalTrials.gov

8. : Vascular Function in Health and Disease

   Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of vasomotion and thus perfusion to the muscle tissue is the host of chemical factors originating from the vascular endotheliu…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   George E Wahlen VA Medical Center, Salt Lake City, Utah

   Run by

   Russell Richardson

   See if you can join NCT02966665 on ClinicalTrials.gov